(Q38911521)

English

Baseline polysaccharide-specific antibodies may not consistently inhibit booster antibody responses in infants to a serogroup C meningococcal protein-polysaccharide conjugate vaccine

scientific article published in May 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Baseline polysaccharide-specific antibodies may not consistently inhibit booster antibody responses in infants to a serogroup C meningococcal protein-polysaccharide conjugate vaccine (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

1 reference

based on heuristic

inferred from title

Andrew J. Pollard

6

object named as

Andrew J Pollard

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Matthew D Snape

5

object named as

Matthew D Snape

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

author name string

Geraldine Blanchard-Rohner

1

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Hilary Watt

2

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Dominic F Kelly

3

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Ly-Mee Yu

4

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

language of work or name

0 references

publication date

1 May 2012

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

30

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

28

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

4153-4159

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Regulation of antibody responses via antibodies, complement, and Fc receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.063

7 January 2021

Feedback regulation by IgG antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.063

7 January 2021

Antibody-mediated regulation of the immune response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.063

7 January 2021

Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.063

7 January 2021

Influence of maternal antibodies on vaccine responses: inhibition of antibody but not T cell responses allows successful early prime-boost strategies in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.063

7 January 2021

Attenuated immune response to tetanus toxoid in young healthy men protected against tetanus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.063

7 January 2021

Short-term booster effect of diphtheria toxoid in initially long-term protected individuals.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.063

7 January 2021

Immune response to diphtheria booster vaccine in the Baltic states

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.063

7 January 2021

Diphtheria booster vaccination: one or two injections?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.063

7 January 2021

The magnitude of the antibody and memory B cell responses during priming with a protein-polysaccharide conjugate vaccine in human infants is associated with the persistence of antibody and the intensity of booster response.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.063

7 January 2021

Methods for assessing whether change depends on initial value

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.063

7 January 2021

Revisiting the relation between change and initial value: a review and evaluation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.063

7 January 2021

A note on the analysis of repeated measurements of the same subjects

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.063

7 January 2021

Immunogenicity and safety of a combination pneumococcal-meningococcal vaccine in infants: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.063

7 January 2021

A randomized study comparing the safety and immunogenicity of a conjugate vaccine combination containing meningococcal group C and pneumococcal capsular polysaccharide--CRM197 with a meningococcal group C conjugate vaccine in healthy infants: challe

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.063

7 January 2021

Safety, immunogenicity, and induction of immunologic memory by a serogroup C meningococcal conjugate vaccine in infants: A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.063

7 January 2021

A randomised, double-blind, controlled trial of the immunogenicity and tolerability of a meningococcal group C conjugate vaccine in young British infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.063

7 January 2021

Demonstration of immunologic memory using serogroup C meningococcal glycoconjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.063

7 January 2021

A novel combined Hib-MenC-TT glycoconjugate vaccine as a booster dose for toddlers: a phase 3 open randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.063

7 January 2021

A new combination haemophilus influenzae type B and Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine for primary immunization of infants.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.063

7 January 2021

A multilevel modelling solution to mathematical coupling.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.063

7 January 2021

Meningococcal vaccines. Current status and future possibilities

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.063

7 January 2021

Kinetics of Antibody Production to Group A and Group C Meningococcal Polysaccharide Vaccines Administered during the First Six Years of Life: Prospects for Routine Immunization of Infants and Children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.063

7 January 2021

Mathematical coupling can undermine the statistical assessment of clinical research: illustration from the treatment of guided tissue regeneration

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.063

7 January 2021

Is reduction of pocket probing depth correlated with the baseline value or is it "mathematical coupling"?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.063

7 January 2021

Glycoconjugate vaccines and immune interference: A review

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.063

7 January 2021

Potential alterations in immunogenicity by combining or simultaneously administering vaccine components.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.063

7 January 2021

Magnitude of interference after diphtheria-tetanus toxoids-acellular pertussis/Haemophilus influenzae type b capsular polysaccharide-tetanus vaccination is related to the number of doses administered

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.063

7 January 2021

Reduced response to multiple vaccines sharing common protein epitopes that are administered simultaneously to infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.063

7 January 2021

based on heuristic

inferred from DOI database lookup

Influence of prevaccination immunity on the human B-lymphocyte response to a Haemophilus influenzae type b conjugate vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.063

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2012.04.063

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38911521&oldid=1795845141"